Table 1. Patient characteristics and treatment complications.

Patient ID	Age at diagnosis, sex	Previous treatment	Time from Diagnosis to center referral	Last follow-up	Total follow-up in months	Biliary pathology on ERC	Post ERC complication	PNM classification
1	32, m	none	Diagnosed in center	5/2015	107	Stenosis of right and left hepatic duct	cholangitis	P4N1M0
2	46, m	ERC with plastic stent	3 months	5/2015	95	Stenosis of common and right hepatic duct	none	P4N0M0
3	45, f	ERC with plastic stent placement,	3 months	12/2014	54	Common hepatic duct destruction, stenosis of right and left hepatic duct	cholangitis	P4N0M0
4	76, m	Albendazole, percutaneous transhepatic cholangio drainage (PTCD)	17 months	2/2014	52	Changes in diameter of common hepatic duct no relevant stenosis	none	P4N1M1
5	43, f	Albendazole, non- curative liver resection	7 years	5/2015	32	Stenosis of common hepatic duct	none	P4N0M0
6	51, m	ERC with plastic stent placement, explorative laparotomy, Albendazole	20 months	12/2014	13	Stenosis of common hepatic duct	none	P4N0M0
7	73, f	Albendazole, ERC with plastic stent placement	4 weeks	3/2015	6	Stenosis of common hepatic duct	none	P4N1M1